Market Research Reports and Industry Reports

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

GlaxoSmithKline Pharmaceuticals Ltd (GSK India) manufactures and markets prescription medicines and vaccines. The prescription medicines range across therapeutic areas such as, analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, central nervous system (CNS) and oncology. The company offers a range of vaccines for the prevention of hepatitis A, hepatitis B, influenzae, diphtheria, tetanus, pertussis, rotavirus, tetanus toxoid, reduced diphtheria toxoid, human papillomavirus vaccine and others. The company is a subsidiary of GlaxoSmithKline Plc, which has operations across pharmaceuticals, vaccines and consumer health domains. GSK India is headquartered in Mumbai, Maharashtra, India.

GlaxoSmithKline Pharmaceuticals Ltd Key Recent Developments

Jul 25,2017: GlaxoSmithKline Pharmaceuticals QI performance temporarily impacted by GST trade channel destocking whilst fundamentals remain intact
Feb 11,2017: GlaxoSmithKline Pharmaceuticals announces change in Directorate
Feb 11,2017: GlaxoSmithKline Pharmaceuticals announcesexecutive director change
Oct 27,2016: GlaxoSmithKline Pharmaceuticals announces a 12% Sales growth for the Quarter Ended 30 September, 2016
Jul 28,2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
GlaxoSmithKline Pharmaceuticals Ltd - Key Facts 5
GlaxoSmithKline Pharmaceuticals Ltd - Key Employees 6
GlaxoSmithKline Pharmaceuticals Ltd - Key Employee Biographies 7
GlaxoSmithKline Pharmaceuticals Ltd - Major Products and Services 8
GlaxoSmithKline Pharmaceuticals Ltd - History 14
GlaxoSmithKline Pharmaceuticals Ltd - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 16
Section 2 Company Analysis 17
GlaxoSmithKline Pharmaceuticals Ltd - Business Description 17
GlaxoSmithKline Pharmaceuticals Ltd - Corporate Strategy 18
GlaxoSmithKline Pharmaceuticals Ltd - SWOT Analysis 19
SWOT Analysis - Overview 19
GlaxoSmithKline Pharmaceuticals Ltd - Strengths 19
GlaxoSmithKline Pharmaceuticals Ltd - Weaknesses 20
GlaxoSmithKline Pharmaceuticals Ltd - Opportunities 21
GlaxoSmithKline Pharmaceuticals Ltd - Threats 22
GlaxoSmithKline Pharmaceuticals Ltd - Key Competitors 23
Section 3 Company Financial Ratios 24
Financial Ratios - Capital Market Ratios 24
Financial Ratios - Annual Ratios 25
Performance Chart 28
Financial Performance 28
Financial Ratios - Ratio Charts 29
Section 4 Companys Lifesciences Financial Deals and Alliances 30
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary 32
Section 5 Companys Recent Developments 33
Jul 25, 2017: GlaxoSmithKline Pharmaceuticals QI performance temporarily impacted by GST trade channel destocking whilst fundamentals remain intact 33
Feb 11, 2017: GlaxoSmithKline Pharmaceuticals announcesexecutive director change 34
Oct 27, 2016: GlaxoSmithKline Pharmaceuticals announces a 12% Sales growth for the Quarter Ended 30 September, 2016 35
Jul 28, 2016: GlaxoSmithKline Pharmaceuticals delivers Q1 performance of 8% Sales growth 36
Mar 04, 2016: WNS Extends Contract with GSK to Provide High-end Analytical Services 37
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 38
Feb 08, 2016: Biogen Joins Pioneering Target Validation Collaboration 39
Jan 12, 2016: Kuehne + Nagel and GlaxoSmithKline sign long term global logistics partnership contract 40
Section 6 Appendix 41
Methodology 41
Ratio Definitions 41
About GlobalData 45
Contact Us 45
Disclaimer 45

List Of Tables


GlaxoSmithKline Pharmaceuticals Ltd, Key Facts 5
GlaxoSmithKline Pharmaceuticals Ltd, Key Employees 6
GlaxoSmithKline Pharmaceuticals Ltd, Key Employee Biographies 7
GlaxoSmithKline Pharmaceuticals Ltd, Major Products and Services 8
GlaxoSmithKline Pharmaceuticals Ltd, History 14
GlaxoSmithKline Pharmaceuticals Ltd, Joint Venture 16
GlaxoSmithKline Pharmaceuticals Ltd, Key Competitors 23
GlaxoSmithKline Pharmaceuticals Ltd, Ratios based on current share price 24
GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios 25
GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios (Cont...1) 26
GlaxoSmithKline Pharmaceuticals Ltd, Annual Ratios (Cont...2) 27
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
GlaxoSmithKline Pharmaceuticals Ltd, Recent Deals Summary 32
Currency Codes 41
Capital Market Ratios 41
Equity Ratios 42
Profitability Ratios 42
Cost Ratios 43
Liquidity Ratios 43
Leverage Ratios 44
Efficiency Ratios 44

List Of Figures


GlaxoSmithKline Pharmaceuticals Ltd, Performance Chart (2013 - 2017) 28
GlaxoSmithKline Pharmaceuticals Ltd, Ratio Charts 29
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
GlaxoSmithKline Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 31

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

GlaxoSmithKline PLC Strategic Analysis Review- GlaxoSmithKline PLC SWOT, Outlook, Operations and Financial Profile

GlaxoSmithKline PLC Company Profile provides strategic analysis of GlaxoSmithKline PLC Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth opportunities available

USD 200View Report

Beximco Pharmaceuticals Ltd (BXPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Beximco Pharmaceuticals Ltd (Beximco Pharma), a subsidiary of Beximco Holdings Ltd is a manufacturer and exporter of pharmaceutical formulations and active pharmaceutical ingredients. The company offers products in the therapeutic

USD 250View Report

Actelion Pharmaceuticals Ltd (ATLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Actelion Pharmaceuticals Ltd (Actelion) is a biopharmaceutical company, which strives to discover, develop and commercialize innovative treatments for diseases with considerable unmet medical needs. The company focuses on the development

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Aug 2017
No. of Pages :45
Country :India
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube